By Phil Bowler, MPhil, Bsc, FIBMS, director, infection prevention and control, research and development, ConvaTec.
While the Centers for Disease Control and Prevention (CDC) recently celebrated a decline in methicillin-resistant Staphylococcus aureus (MRSA) infections[i], incidences of several other types of multidrug-resistant organisms (MDROs) known as ‘superbugs’ continue to rise and precautions need to be taken in hospitals and home…Continue
Posted on August 24, 2012 at 10:55am
ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, announced observational study results showing that use of ConvaTec Moldable Technology™ Skin Barriers helped to maintain skin integrity and improve peristomal skin issues in stoma patients. The final study results were presented…Continue
Posted on June 20, 2012 at 9:18am
On Monday, May 28, ConvaTec will host a live international webcast to review data on the effectiveness of silver in wound dressings. The webcast will be held at 16:30 (KST) from the ASAN Medical Center in Seoul, South Korea and will be available at www.convatecevidence.com. It will include a live question and answer session following the presentation. Participants can pre-register for the webcast and submit a question for the speakers in advance…Continue
Posted on April 19, 2012 at 11:30am